Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, and ...

The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of biotech executives, patient groups and conservative allies of President ...

Vinay Prasad, the top vaccine regulator and chief scientific officer at the Food and Drug Administration (FDA) and a critic ...

A controversial hematologist-oncologist who joined FDA this spring and quickly became its top regulator has left the ...

The U.S. Food and Drug Administration's top vaccine official, Vinay Prasad, has left the agency after just three months as Director of the Center for Biologics Evaluation and Research, a government ...

Vinay Prasad, FDA's top vaccine official, has resigned after three months amid criticism and controversy, especially concerning the FDA's handling of a gene therapy for Duchenne muscular dystrophy.

FDA Commissioner Marty Makary said the FDA’s review process will not slow down despite layoffs at the Department of Health and Human Services.

British pharmaceutical giant GSK Plc (NYSE:GSK) shares rose on Wednesday after reporting second-quarter results that surpassed analyst expectations and led the company to raise its full-year 2025 ...

WASHINGTON (AP) — The Trump administration is pushing an initiative for millions of Americans to upload personal health data ...

WASHINGTON (AP) — The Trump administration is freezing $108 million in research funding to Duke University as the federal government accuses the school of racial discrimination in the form of ...